Paratek Pharmaceuticals to Host Investor Update on the Global Opportunity in Non-Tuberculous Mycobacteria (NTM)

September 26, 2022

https://www.globenewswire.com/news-release/2022/09/26/2522562/33636/en/Paratek-Pharmaceuticals-to-Host-Investor-Update-on-the-Global-Opportunity-in-Non-Tuberculous-Mycobacteria-NTM.html

BOSTON, Sept. 26, 2022 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government and military use today announces that the company will host an update for investors on the global opportunity for NUZYRA® (omadacycline) in non-tuberculous mycobacteria (NTM) on Monday, Oct. 3 from 10:30 a.m. to noon Eastern time.

Read more at globenewswire.com

Related news for (PRTK)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.